Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Soft Tissue Sarcoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00006379
What this trial is testing

Non-Ablative Allo HSCT For Hematologic Malignancies or SAA

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+5 more
Case Comprehensive Cancer Center 58
Testing effectiveness (Phase 2)Study completedNCT01529827
What this trial is testing

Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+75 more
Roswell Park Cancer Institute 94
Testing effectiveness (Phase 2)Study completedNCT03320330
What this trial is testing

Pepinemab in Treating Younger Patients With Recurrent, Relapsed, or Refractory Solid Tumors

Who this might be right for
Recurrent Malignant Solid NeoplasmRecurrent OsteosarcomaRefractory Malignant Solid Neoplasm+1 more
Children's Oncology Group 26
Testing effectiveness (Phase 2)Temporarily pausedNCT03316573
What this trial is testing

Pembrolizumab in Neoplasms or Lymphomas

Who this might be right for
LymphomaHistiocytic SarcomaFollicular Dendritic Cell Sarcoma+1 more
Dana-Farber Cancer Institute 18
Not applicableNot Yet RecruitingNCT07492823
What this trial is testing

Clinical Applicability of Liquid Biopsy in Chondrosarcoma

Who this might be right for
Chondrosarcoma of the Bone
Medical University of Graz 60
Not applicableActive Not RecruitingNCT06452446
What this trial is testing

Telehealth-based Symptom Management for Veterans Treated With Selinexor

Who this might be right for
Multiple MyelomaLarge-cell Lymphoma
Durham VA Medical Center 20
Not applicableStudy completedNCT04377360
What this trial is testing

Feasibility Trial of Diffusing Alpha-emitter Radiation Therapy (DaRT) for Malignant Skin & Superficial Soft Tissue Tumors

Who this might be right for
Malignant Skin TumorSoft Tissue Tumor, Malignant
Alpha Tau Medical LTD. 10
Testing effectiveness (Phase 2)Study completedNCT00002673
What this trial is testing

Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation

Who this might be right for
Cancer
Fred Hutchinson Cancer Center 30
Early research (Phase 1)Study completedNCT00005092
What this trial is testing

Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
M.D. Anderson Cancer Center 7
Testing effectiveness (Phase 2)Study completedNCT00041236
What this trial is testing

Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma

Who this might be right for
Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC 39
Not applicableLooking for participantsNCT01772771
What this trial is testing

Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program

Who this might be right for
GliomaHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm+2 more
M.D. Anderson Cancer Center 12,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07741877
What this trial is testing

Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Soft Tissue Sarcoma

Who this might be right for
SarcomaSoft Tissue Sarcoma (STS)Advanced Soft Tissue Sarcoma+2 more
Iovance Biotherapeutics, Inc. 80
Not applicableLooking for participantsNCT07552467
What this trial is testing

Sub-topic Four: Clinical Translation of Original Radioactive Drugs for Precision Diagnosis and Treatment of Gastrointestinal Tumors -Clinical Application Value of PET Imaging Targeting LRRC15 in Malignant Tumors

Who this might be right for
Pancreatic CancerBreast CancerLung Cancer+5 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 26
Early research (Phase 1)Study completedNCT00020267
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Lung CancerAdult Soft Tissue SarcomaColorectal Cancer+8 more
National Cancer Institute (NCI)
Not applicableLooking for participantsNCT07057765
What this trial is testing

Predictive Value of CRP, Albumin, CAR, and mGPS in Treatment Outcomes of DLBCL

Who this might be right for
DLBCL - Diffuse Large B Cell LymphomaMarkers of Inflammation
Ain Shams University 40
Testing effectiveness (Phase 2)Ended earlyNCT06630325
What this trial is testing

A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer

Who this might be right for
Advanced Breast CarcinomaAdvanced Malignant Solid NeoplasmAdvanced Ovarian Carcinoma+11 more
OHSU Knight Cancer Institute 6
Not applicableStudy completedNCT05510908
What this trial is testing

Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC

Who this might be right for
HIV-Associated Malignant NeoplasmHIV InfectionsCancer+5 more
AIDS Malignancy Consortium 460
Testing effectiveness (Phase 2)Active Not RecruitingNCT03213652
What this trial is testing

Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmMalignant Solid NeoplasmRecurrent Ependymoma+30 more
National Cancer Institute (NCI) 13
Testing effectiveness (Phase 2)Study completedNCT03220035
What this trial is testing

Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmAnn Arbor Stage III Childhood Non-Hodgkin LymphomaAnn Arbor Stage IV Childhood Non-Hodgkin Lymphoma+20 more
National Cancer Institute (NCI) 4
Testing effectiveness (Phase 2)Study completedNCT00118326
What this trial is testing

Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease

Who this might be right for
Kidney CancerLeukemiaLymphoma+3 more
Fred Hutchinson Cancer Center
Next Page